These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6205183)

  • 1. [Serum pancreatic secretory trypsin inhibitor (PSTI), amylase activity and pancreatic isoamylase activity in pancreatic diseases].
    Suehiro I; Otsuki M; Oka T; Okabayashi Y; Ohki A; Kanda T; Yuu H; Maeda M; Yamasaki T; Baba S
    Nihon Shokakibyo Gakkai Zasshi; 1984 Apr; 81(4):1044-9. PubMed ID: 6205183
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum pancreatic secretory trypsin inhibitor in pancreatic disease.
    Otsuki M; Oka T; Suehiro I; Okabayashi Y; Ohki A; Yuu H; Baba S
    Clin Chim Acta; 1984 Sep; 142(2):231-40. PubMed ID: 6209036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The measurement of serum immunoreactive pancreatic secretory trypsin inhibitor in gastrointestinal cancer and pancreatic disease.
    Satake K; Inui A; Sogabe T; Yoshii Y; Nakata B; Tanaka H; Chung YS; Hiura A; Umeyama K
    Int J Pancreatol; 1988 Jul; 3(5):323-31. PubMed ID: 2459273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of canine serum total amylase and isoamylase activity determinations.
    Jacobs RM; Swenson CL; Davenport DJ; Murtaugh RJ
    Can J Vet Res; 1988 Oct; 52(4):473-5. PubMed ID: 2461794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of serum pancreatic enzymes in the quiescent phase of chronic pancreatitis.
    Lesi C; Melzi D'Eril GV; Pavesi F; Scandellari A; Faccenda F; Grazia Casertano M; Savoia M; Zoni L; Peppi M
    Clin Biochem; 1985 Aug; 18(4):235-8. PubMed ID: 2412726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amylase, pancreatic isoamylase and lipase in serum before and after endoscopic pancreatography.
    Fjøsne U; Waldum HL; Romslo I; Kleveland PM; Johnsen H; Engebretsen LF
    Acta Med Scand; 1986; 219(3):301-4. PubMed ID: 2422881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of serum pancreatic isoamylase, lipase, and trypsin-like immunoreactivity in pancreatic disease.
    Ventrucci M; Gullo L; Daniele C; Bartolucci C; Priori P; Platé L; Bonora G; Labò G
    Digestion; 1983; 28(2):114-21. PubMed ID: 6197334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of pancreatic enzyme levels with the patient's recovery from acute edematous pancreatitis.
    Lankisch PG; Buschmann-Kaspari H; Otto J; Schröder K; Koop H
    Klin Wochenschr; 1990 Jun; 68(11):565-9. PubMed ID: 1695957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of immunoreactive trypsin and activity of pancreatic isoamylase in serum compared in pancreatic diseases.
    Fahrenkrug J; Magid E
    Clin Chem; 1980 Oct; 26(11):1573-6. PubMed ID: 6158383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of serum amylase pancreatic isoamylase and lipase in patients with hyperamylasemia.
    Kolars JC; Ellis CJ; Levitt MD
    Dig Dis Sci; 1984 Apr; 29(4):289-93. PubMed ID: 6200276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of xylazine administration on serum amylase, pancreas-specific isoamylase and pancreatic polypeptide in normal dogs.
    Jacobs RM; Murtaugh RJ; Sherding RG; O'Dorisio TM
    Can J Vet Res; 1986 Jan; 50(1):123-5. PubMed ID: 2427175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between serum pancreatic isoamylase concentration and pancreatic exocrine function.
    Johnson SG; Levitt MD
    Am J Dig Dis; 1978 Oct; 23(10):914-8. PubMed ID: 717351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels of immunoreactive PSTI in acute abdominal disorders, with special reference to a possible extrapancreatic PSTI production.
    Lasson A; Borgström A; Ohlsson K
    Clin Chim Acta; 1986 Nov; 161(1):37-46. PubMed ID: 2434267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnostic significance of pancreatic serum-enzyme patterns after stimulation with secretin in chronic pancreatitis (author's transl)].
    Malfertheiner P; Bieger W; Trischler G; Ditschuneit H
    Dtsch Med Wochenschr; 1982 Jun; 107(22):849-53. PubMed ID: 6177482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extrapancreatic origin of chronic unexplained hyperamylasemia.
    Levitt MD; Ellis CJ; Meier PB
    N Engl J Med; 1980 Mar; 302(12):670-1. PubMed ID: 6153453
    [No Abstract]   [Full Text] [Related]  

  • 16. Elevated levels of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with malabsorption syndrome.
    Nakano I; Funakoshi A; Kimura T; Miyata Y; Koga S; Ibayashi H
    Gastroenterol Jpn; 1986 Dec; 21(6):617-22. PubMed ID: 2436966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of an inhibitor assay to determine serum isoamylase distribution.
    Ellis C; Koehler DF; Eckfeldt JH; Levitt MD
    Dig Dis Sci; 1982 Oct; 27(10):897-901. PubMed ID: 6180877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevation of serum pancreatic secretory trypsin inhibitor (PSTI) in patients with serious injury.
    Ogawa M; Matsuda K; Shibata T; Matsuda Y; Ukai T; Ohta M; Mori T
    Res Commun Chem Pathol Pharmacol; 1985 Nov; 50(2):259-66. PubMed ID: 2417295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpancreatic-type hyperamylasemia associated with pancreatic cancer.
    Shimamura J; Fridhandler L; Berk JE
    Am J Dig Dis; 1976 Apr; 21(4):340-5. PubMed ID: 1274925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential determination of serum isoamylase using an amylase inhibitor and its clinical application.
    Kameya A; Hayakawa T; Noda A; Kondo T
    Am J Gastroenterol; 1985 Jan; 80(1):54-9. PubMed ID: 3966456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.